Albiglutide, marketed under the brand name Tanzeum, is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for the treatment of type 2 diabetes mellitus. It is a long-acting injectable medication designed to help improve blood sugar control in adults. Albiglutide is a dipeptidyl peptidase-4 (DPP-4) resistant analog of human GLP-1, meaning it is modified to last longer in the body compared to natural GLP-1. It is administered once weekly. (FDA label, DrugBank)
Deep dive
Tap a section to expand.
Known interactions
Category rule: glp1 × supplement
Note
GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.
Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Sources referenced
* Cochrane Review
* DrugBank
* EMA SmPC (Summary of Product Characteristics)
* Examine.com
* FDA Label (U.S. Food and Drug Administration)
* Mayo Clinic
* MedlinePlus (National Library of Medicine)
* NIH ODS (National Institutes of Health Office of Dietary Supplements)
* PubChem (National Library of Medicine)
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the glp1 category or studied for the same goals.
